These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24373324)

  • 1. A fusion protein derived from plants holds promising potential as a new oral therapy for type 2 diabetes.
    Choi J; Diao H; Feng ZC; Lau A; Wang R; Jevnikar AM; Ma S
    Plant Biotechnol J; 2014 May; 12(4):425-35. PubMed ID: 24373324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral delivery of bioencapsulated exendin-4 expressed in chloroplasts lowers blood glucose level in mice and stimulates insulin secretion in beta-TC6 cells.
    Kwon KC; Nityanandam R; New JS; Daniell H
    Plant Biotechnol J; 2013 Jan; 11(1):77-86. PubMed ID: 23078126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GLP-1 and type 2 diabetes: physiology and new clinical advances.
    Combettes MM
    Curr Opin Pharmacol; 2006 Dec; 6(6):598-605. PubMed ID: 16987706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transferrin fusion technology: a novel approach to prolonging biological half-life of insulinotropic peptides.
    Kim BJ; Zhou J; Martin B; Carlson OD; Maudsley S; Greig NH; Mattson MP; Ladenheim EE; Wustner J; Turner A; Sadeghi H; Egan JM
    J Pharmacol Exp Ther; 2010 Sep; 334(3):682-92. PubMed ID: 20498254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel GLP-1/xenin hybrid peptide improves glucose homeostasis, circulating lipids and restores GIP sensitivity in high fat fed mice.
    Hasib A; Ng MT; Khan D; Gault VA; Flatt PR; Irwin N
    Peptides; 2018 Feb; 100():202-211. PubMed ID: 29412820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel exendin-4 human serum albumin fusion protein, E2HSA, with an extended half-life and good glucoregulatory effect in healthy rhesus monkeys.
    Zhang L; Wang L; Meng Z; Gan H; Gu R; Wu Z; Gao L; Zhu X; Sun W; Li J; Zheng Y; Dou G
    Biochem Biophys Res Commun; 2014 Mar; 445(2):511-6. PubMed ID: 24565847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of exendin-4 on glucose tolerance, insulin secretion, and beta-cell proliferation depend on treatment dose, treatment duration and meal contents.
    Arakawa M; Ebato C; Mita T; Hirose T; Kawamori R; Fujitani Y; Watada H
    Biochem Biophys Res Commun; 2009 Dec; 390(3):809-14. PubMed ID: 19836346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The entero-insular axis: implications for human metabolism.
    Ranganath LR
    Clin Chem Lab Med; 2008; 46(1):43-56. PubMed ID: 18020966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plant-derived recombinant human serum transferrin demonstrates multiple functions.
    Brandsma ME; Diao H; Wang X; Kohalmi SE; Jevnikar AM; Ma S
    Plant Biotechnol J; 2010 May; 8(4):489-505. PubMed ID: 20432512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta-cell failure in diabetes and preservation by clinical treatment.
    Wajchenberg BL
    Endocr Rev; 2007 Apr; 28(2):187-218. PubMed ID: 17353295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists.
    Nakashima R; Yano T; Ogawa J; Tanaka N; Toda N; Yoshida M; Takano R; Inoue M; Honda T; Kume S; Matsumoto K
    Eur J Pharmacol; 2014 Aug; 737():194-201. PubMed ID: 24858371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute but not chronic activation of brain glucagon-like peptide-1 receptors enhances glucose-stimulated insulin secretion in mice.
    Tudurí E; Beiroa D; Porteiro B; López M; Diéguez C; Nogueiras R
    Diabetes Obes Metab; 2015 Aug; 17(8):789-99. PubMed ID: 25962313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DsAAV8-mediated expression of glucagon-like peptide-1 in pancreatic beta-cells ameliorates streptozotocin-induced diabetes.
    Riedel MJ; Gaddy DF; Asadi A; Robbins PD; Kieffer TJ
    Gene Ther; 2010 Feb; 17(2):171-80. PubMed ID: 19865180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of independent and combined metabolic effects of chronic treatment with (pGlu-Gln)-CCK-8 and long-acting GLP-1 and GIP mimetics in high fat-fed mice.
    Irwin N; Hunter K; Montgomery IA; Flatt PR
    Diabetes Obes Metab; 2013 Jul; 15(7):650-9. PubMed ID: 23388064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential New Approaches to Modifying Intestinal GLP-1 Secretion in Patients with Type 2 Diabetes Mellitus : Focus on Bile Acid Sequestrants.
    Holst JJ; McGill MA
    Clin Drug Investig; 2012 Jan; 32(1):1-14. PubMed ID: 27933595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release.
    Chu ZL; Carroll C; Alfonso J; Gutierrez V; He H; Lucman A; Pedraza M; Mondala H; Gao H; Bagnol D; Chen R; Jones RM; Behan DP; Leonard J
    Endocrinology; 2008 May; 149(5):2038-47. PubMed ID: 18202141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral administration of corn zein hydrolysate stimulates GLP-1 and GIP secretion and improves glucose tolerance in male normal rats and Goto-Kakizaki rats.
    Higuchi N; Hira T; Yamada N; Hara H
    Endocrinology; 2013 Sep; 154(9):3089-98. PubMed ID: 23798598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exendin-4 upregulates the expression of Wnt-4, a novel regulator of pancreatic β-cell proliferation.
    Heller C; Kühn MC; Mülders-Opgenoorth B; Schott M; Willenberg HS; Scherbaum WA; Schinner S
    Am J Physiol Endocrinol Metab; 2011 Nov; 301(5):E864-72. PubMed ID: 21771967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodality imaging of β-cells in mouse models of type 1 and 2 diabetes.
    Yong J; Rasooly J; Dang H; Lu Y; Middleton B; Zhang Z; Hon L; Namavari M; Stout DB; Atkinson MA; Tian J; Gambhir SS; Kaufman DL
    Diabetes; 2011 May; 60(5):1383-92. PubMed ID: 21441442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells.
    Lee YS; Jun HS
    Metabolism; 2014 Jan; 63(1):9-19. PubMed ID: 24140094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.